Molecular model of the μ-opiate receptorBRANDT, W; BARTH, A.Regulatory peptides. 1994, pp S61-S62, issn 0167-0115, SUP1Conference Paper

Multiple mu opiate receptors: biochemical and pharmacological evidence for multiplicityPASTERNAK, G. W.Biochemical pharmacology. 1986, Vol 35, Num 3, pp 361-364, issn 0006-2952Article

Single-channel observations on the mu-opioid receptorSMUDA, J. W; DE LEVIE, R.Biophysical journal. 1986, Vol 50, Num 4, pp 759-760, issn 0006-3495Article

Resolution in the receptor binding of putative μ and κ opiatesMEDZIHRADSKY, F; DAHLSTROM, P. J; WOODS, J. H et al.Life sciences (1973). 1984, Vol 34, Num 22, pp 2129-2138, issn 0024-3205Article

Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate Mu receptor whose binding is characterized by low nonspecific bindingROTHMAN, R. B; DANKS, J. A; JACOBSON, A. E et al.Neuropeptides (Edinburgh). 1984, Vol 4, Num 4, pp 311-317, issn 0143-4179Article

Intact brain cells: a novel model system for studying opioid receptor bindingROGERS, N. F; EL-FAKAHANY, E. E.Life sciences (1973). 1985, Vol 37, Num 4, pp 307-314, issn 0024-3205Article

Inhibition via opioid μ- and δ-receptors of vagal transmission in rabbit isolated heartWEITZELL, R; ILLES, P; STARKE, K et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 2, pp 186-190, issn 0028-1298Article

Remifentanil : A novel, short-acting, μ-opioidBÜRKLE, H; DUNBAR, S; VAN AKEN, H et al.Anesthesia and analgesia. 1996, Vol 83, Num 3, pp 646-651, issn 0003-2999Article

Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximusKAVALIERS, M; RANGELEY, R. W; HIRST, M et al.Pharmacology, biochemistry and behavior. 1986, Vol 24, Num 3, pp 561-566, issn 0091-3057Article

Kinetic evidence for differential agonist and antagonist binding to bovine hippocampal synaptic membrane opioid receptorsSCHEIBE, S. D; BENNETT, D. B; SPIN, J. W et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 21, pp 13298-13303, issn 0021-9258Article

Constitutive μ opioid receptor activity in human neuroblastoma SK-N-SH cellsZAIJIE WANG; SADEE, W.Regulatory peptides. 1994, pp S283-S284, issn 0167-0115, SUP1Conference Paper

Exploration of a chemical series as a drug discovery strategyLEDNICER, D.Drug design and delivery. 1988, Vol 2, Num 1, pp 69-78, issn 0884-2884Article

A μ-opioid receptor-filter assay: rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand-receptor complexesILIEN, B; GALZI, J.-L; MEJEAN, A et al.Biochemical pharmacology. 1988, Vol 37, Num 20, pp 3843-3851, issn 0006-2952Article

Phosphatidylinositol turnover in neuroblastoma cells: regulation by bradykinin, acetylcholine, but not μ- and δ-opioid receptorsYU, V. C; SADEE, W.Neuroscience letters. 1986, Vol 71, Num 2, pp 219-223, issn 0304-3940Article

The effects of the acute administration of buprenorphine hydrochloride on the release of anterior pituitary hormones in the rat: evidence for the involvement of multiple opiate receptorsPECHNICK, R. N; GEORGE, R; POLAND, R. E et al.Life sciences (1973). 1985, Vol 37, Num 20, pp 1861-1868, issn 0024-3205Article

Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH₂) and related peptides to μ₁ and μ₂ opiate receptorsZADINA, J. E; PAUL, D; GERGEN, K. A et al.Neuroscience letters. 1996, Vol 215, Num 1, pp 65-69, issn 0304-3940Article

Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific μ opioid receptor antagonists with greatly reduced binding at somatostatin receptorsKAZMIERSKI, W; WIRE, W. S; LUI, G. K et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 11, pp 2170-2177, issn 0022-2623Article

Isolation of a specific μ-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteinsKWEN-JEN CHANG; YING FU SU; BRENT, D. A et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 17, pp 9706-9712, issn 0021-9258Article

Presence in neuroblastoma cells of a μ₃ receptor with selectivity for opiate alkaloids but without affinity for opioid peptidesCRUCIANI, R. A; DVORKIN, B; KLINGER, H. P et al.Brain research. 1994, Vol 667, Num 2, pp 229-237, issn 0006-8993Article

Agonist and antagonist properties of dihydroetorphine for μ-opioid receptors in miceKAMEI, J; SUZUKI, T; NAGASE, H et al.Neuroscience letters. 1996, Vol 215, Num 2, pp 87-90, issn 0304-3940Article

μ Opiate receptor immunoreactivity in rat central nervous systemMORIWAKI, A; WANG, J.-B; SVINGOS, A et al.Neurochemical research. 1996, Vol 21, Num 11, pp 1315-1331, issn 0364-3190Article

Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cellsARDEN, J. R; SEGREDO, V; ZAIJIE WANG et al.Journal of neurochemistry. 1995, Vol 65, Num 4, pp 1636-1645, issn 0022-3042Article

Theoretical conformational analysis of the opioid δ antagonist H-Tyr-Tic-Phe-OH and the μ agonist H-Tyr-D-Tic-Phe-NH₂WILKES, B. C; SCHILLER, P. W.Biopolymers. 1994, Vol 34, Num 9, pp 1213-1219, issn 0006-3525Article

In vivo determination of μ opioid receptor reserve and turnover in rhesus monkeys after irreversible blockade with clocinnamoxZERNIG, G; BUTELMAN, E. R; LEWIS, J et al.Regulatory peptides. 1994, pp S59-S60, issn 0167-0115, SUP1Conference Paper

Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by nor-binaltorphiminePARONIS, C. A; WADDELL, A. B; HOLTZMAN, S. G et al.Pharmacology, biochemistry and behavior. 1993, Vol 46, Num 4, pp 813-817, issn 0091-3057Article